Diabetes, Hypertension and Cardiovascular Disease: Clinical Insights, Mechanisms and Pharmacotherapies
- PMID: 38674212
- PMCID: PMC11052317
- DOI: 10.3390/medicina60040566
Diabetes, Hypertension and Cardiovascular Disease: Clinical Insights, Mechanisms and Pharmacotherapies
Abstract
Cardiovascular disease (CVD) is a serious issue demanding world attention, not only because of its role in increased mortality, but also in conjunction with the aging population and growing prevalence of other co-morbidities, such as hypertension, diabetes, etc [...].
Conflict of interest statement
The author declares no conflicts of interest.
Similar articles
-
Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.Vascul Pharmacol. 2017 Apr;91:10-17. doi: 10.1016/j.vph.2017.03.004. Epub 2017 Mar 22. Vascul Pharmacol. 2017. PMID: 28342822 Review.
-
Risk factors for and management of post-transplantation cardiovascular disease.BioDrugs. 2001;15(4):261-78. doi: 10.2165/00063030-200115040-00006. BioDrugs. 2001. PMID: 11437691 Review.
-
Brief comments on the issue of cardiovascular risk in diabetic patients.Am J Hypertens. 2004 Jul;17(7):640. doi: 10.1016/j.amjhyper.2004.03.677. Am J Hypertens. 2004. PMID: 15233987 No abstract available.
-
New drugs and clinical trials in diabetes and hypertension.Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:64-9. doi: 10.1055/s-0029-1211801. Exp Clin Endocrinol Diabetes. 1997. PMID: 9288549 Review.
-
Arresting cardiovascular disease progression. Early treatment may counteract high risk.Postgrad Med. 2004 Aug;116(2):45-8. doi: 10.3810/pgm.2004.08.1570. Postgrad Med. 2004. PMID: 15323153 Review.
Cited by
-
The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study.Cardiovasc Diabetol. 2025 May 21;24(1):218. doi: 10.1186/s12933-025-02783-9. Cardiovasc Diabetol. 2025. PMID: 40399902 Free PMC article.
-
Population and Co-Occurrence Characteristics of Diagnoses and Comorbidities in Coronary Artery Disease Patients: A Case Study from a Hospital in Guangxi, China.Bioengineering (Basel). 2024 Dec 18;11(12):1284. doi: 10.3390/bioengineering11121284. Bioengineering (Basel). 2024. PMID: 39768102 Free PMC article.
References
-
- Global Burden of Disease Collaborative Network . Global Burden of Disease Study 2019 (GBD 2019) Results. Institute for Health Metrics and Evaluation; Seattle, WA, USA: 2020. [(accessed on 3 December 2023)]. Available online: http://ghdx.healthdata.org/gbd-results-tool.
-
- The Global Cardiovascular Risk Consortium. Magnussen C., Ojeda F.M., Leong D.P., Alegre-Diaz J., Amouyel P., Aviles-Santa L., De Bacquer D., Ballantyne C.M., Bernabé-Ortiz A., et al. Global effect of modifiable risk factors on cardiovascular disease and mortality. N. Engl. J. Med. 2023;389:1273–1285. doi: 10.1056/NEJMoa2206916. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical